Alzheimers Drugs Market 2028 By Drug, Distribution Channel | The Insight Partners

report image

Alzheimers Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Donepezil, Rivastigmine, Galantamine, Memantine); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales)

Report Code: TIPRE00015800 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Alzheimers disease (AD) is a progressive, degenerative disorder that attacks the brain's nerve cells or neurons, resulting in loss of memory, thinking and language skills, and behavioral changes.


The alzheimer's drugs market is driving due to growing numbers of clinical trials focusing on preclinical along with increasing prevalence of AD and mild cognitive impairment across the globe. However, high failure rates of late-stage drugs which might hamper the market growth in the review period.


The "Alzheimers Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of alzheimer's drugs market with detailed market segmentation by drug, and distribution channel. The alzheimer's drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in alzheimer's drugs market and offers key trends and opportunities in the market.


The alzheimer's drugs market is segmented on the basis of drug, and distribution channel. On the basis of drug, the market is segmented into donepezil, rivastigmine, galantamine and memantine. On the basis of distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online sales.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Alzheimers Drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Alzheimers Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Alzheimers Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Alzheimers Drugs market in these regions.

Get more information on this report :


The report covers key developments in the alzheimer's drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from alzheimer's drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for alzheimer's drugs market in the global market. Below mentioned is the list of few companies engaged in the alzheimer's drugs market.

The report also includes the profiles of key players in alzheimer's drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pfizer, Inc.
  •  Janssen Pharmaceutical
  •  Novartis International AG
  •  Eisai Co. Ltd.
  •  Lundbeck A/S
  •  Teva Pharmaceuticals Industries Ltd.
  •  Eli Lilly and Company
  •  TauRx Pharmaceuticals Ltd
  •  VTV Therapeutics
  •  Hoffman-La Roche Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Pfizer, Inc.
2. Janssen Pharmaceutical
3. Novartis International AG
4. Eisai Co. Ltd.
5. Lundbeck A/S
6. Teva Pharmaceuticals Industries Ltd.
7. Eli Lilly and Company
8. TauRx Pharmaceuticals Ltd
9. VTV Therapeutics
10. Hoffman-La Roche Ltd.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount